DBA Applied BioSystems (UK) Ltd 12393423 false 2022-02-01 2023-01-31 2023-01-31 The principal activity of the company is The manufacture of soap, detergents, perfumes and toliet preparations Digita Accounts Production Advanced 6.30.9574.0 true 12393423 2022-02-01 2023-01-31 12393423 2023-01-31 12393423 bus:CompanySecretaryDirector1 2023-01-31 12393423 bus:Director2 2023-01-31 12393423 core:CurrentFinancialInstruments core:WithinOneYear 2023-01-31 12393423 core:Non-currentFinancialInstruments core:AfterOneYear 2023-01-31 12393423 bus:Micro-entities 2022-02-01 2023-01-31 12393423 bus:Audited 2022-02-01 2023-01-31 12393423 bus:FullAccounts 2022-02-01 2023-01-31 12393423 bus:SmallCompaniesRegimeForAccounts 2022-02-01 2023-01-31 12393423 bus:RegisteredOffice 2022-02-01 2023-01-31 12393423 bus:CompanySecretaryDirector1 2022-02-01 2023-01-31 12393423 bus:Director2 2022-02-01 2023-01-31 12393423 bus:PrivateLimitedCompanyLtd 2022-02-01 2023-01-31 12393423 countries:England 2022-02-01 2023-01-31 12393423 2021-02-01 2022-01-31 12393423 2022-01-31 12393423 core:CurrentFinancialInstruments core:WithinOneYear 2022-01-31 12393423 core:Non-currentFinancialInstruments core:AfterOneYear 2022-01-31 iso4217:GBP xbrli:pure

Registration number: 12393423

DBA Applied BioSystems (UK) Ltd

Annual Report and Financial Statements

for the Year Ended 31 January 2023

 

DBA Applied BioSystems (UK) Ltd

Contents

Company Information

1

Director's Report

2

Accountants' Report

3

Balance Sheet

4 to 5

Notes to the Financial Statements

4

 

DBA Applied BioSystems (UK) Ltd

Company Information

Director

Charlotte Mantor

Registered office

Common Farm
Frog Lane
Pickmere
Knutsford
WA16 0JG

Accountants

KAH Services Ltd
Liverpool
Merseyside
L23 0SA

 

DBA Applied BioSystems (UK) Ltd

Director's Report for the Year Ended 31 January 2023

The director presents her report and the financial statements for the year ended 31 January 2023.

This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

Directors of the company

The directors who held office during the year were as follows:

Mr David Adimpong - Company secretary and director (ceased 1 December 2022)

Charlotte Mantor (appointed 1 December 2022)

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 17 October 2023
 

.........................................
Charlotte Mantor
Director

 

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
DBA Applied BioSystems (UK) Ltd
for the Year Ended 31 January 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of DBA Applied BioSystems (UK) Ltd for the year ended 31 January 2023 as set out on pages 4 to 5 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Chartered Institute of Management Accountants (CIMA), we are subject to its ethical and other professional requirements. These are based on the principles approved by IFAC.

This report is made solely to the Board of Directors of DBA Applied BioSystems (UK) Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of DBA Applied BioSystems (UK) Ltd and state those matters that we have agreed to state to the Board of Directors of DBA Applied BioSystems (UK) Ltd, as a body, in this report in accordance with the rules as laid down by CIMA. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than DBA Applied BioSystems (UK) Ltd and its Board of Directors as a body for our work or for this report.

 

DBA Applied BioSystems (UK) Ltd

(Registration number: 12393423)
Balance Sheet as at 31 January 2023

2023
£

2022
£

Fixed assets

14,762

25,038

Current assets

35,201

38,317

Prepayments and accrued income

1,000

-

Creditors: Amounts falling due within one year

(24,617)

(27,250)

Net current assets

11,584

11,067

Total assets less current liabilities

26,346

36,105

Creditors: Amounts falling due after more than one year

(37,796)

(44,676)

Accruals and deferred income

(960)

(1,440)

 

(12,410)

(10,011)

Capital and reserves

(12,410)

(10,011)

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Common Farm
Frog Lane
Pickmere
Knutsford
WA16 0JG

These financial statements were authorised for issue by the director on 17 October 2023.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2022 - 1).

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the director on 17 October 2023
 

 

DBA Applied BioSystems (UK) Ltd

(Registration number: 12393423)
Balance Sheet as at 31 January 2023

.........................................
Charlotte Mantor
Director